Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial-Reference-Cited by-同舟云学术

Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial

Published:2002-07 Issue:9327 Volume:360 Page:103-108
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Bolla Michel,Collette Laurence,Blank Léo,Warde Padraig,Dubois Jean Bernard,Mirimanoff René-Olivier,Storme Guy,Bernier Jacques,Kuten Abraham,Sternberg Cora,Mattelaer Johan,Torecilla José Lopez,Pfeffer J Rafael,Cutajar Carmel Lino,Zurlo Alfredo,Pierart Marianne

Publisher

Elsevier BV

Subject

General Medicine

Reference27 articles.

1. Handbook for reporting results of cancer treatment,1979

2. Status of radiation treatment of prostate cancer at Standford University;Bagshaw;Monogr Natl Cancer Inst,1988

3. External beam irradiation of cancer prostate: conformal treatment techniques and outcomes for the 1990s;Hanks;Cancer,1995

4. Preliminary results of a randomized dose-esacalation study comparing 70 Gy to 78 Gy for the treatment of prostate cancer;Pollack;Int J Radiat Oncol Biol Phys,1999

5. Phase III trial of androgen suppression using goserilin in unfavorable prognosis carcinoma of the prostate treated with definitive radiotherapy: Report of Radiation Therapy Oncology Group Protocol 85–31;Pilepich;J Clin Oncol,1997

Cited by 1494 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Phase 1 Trial of Salvage Stereotactic Body Radiation Therapy for Radiorecurrent Prostate Cancer After Brachytherapy;International Journal of Radiation Oncology*Biology*Physics;2024-08

2. Radiation Therapy for Locally Advanced Prostate Cancer: How Do We Treat Patients with cN1 Disease?;European Urology Focus;2024-07

3. Using the Cell-Cycle Risk Score to Predict the Benefit of Androgen-Deprivation Therapy Added to Radiation Therapy in Patients With Newly Diagnosed Prostate Cancer;JCO Precision Oncology;2024-05

4. A Phase II Study of Rucaparib Monotherapy in Nonmetastatic, Hormone-Sensitive Prostate Cancer Demonstrating “BRCAness” Genotype (ROAR);The Oncologist;2024-03-07

5. Prostate Cancer;Geriatric Medicine;2024